|
| Philips will once again deliver the very latest in energy-efficient LED lighting in its role as official lighting partner to the world-renowned New Year’s Eve Times Square Ball. |
|
| Philips today announced it has acquired the aerosol therapy business of Medel SpA in Italy. |
|
| Philips announced today it welcomes the decision made by the European Union to phase-out incandescent light bulbs in the EU by 2012. This decision is in line with Philips' call for action to accelerate the switch over to energy efficient lighting solutions in view of climate change, as announced in Brussels on 7 December 2006. |
|
| At a meeting with investors and financial analysts today on Philips' Consumer Lifestyle sector, Gerard Kleisterlee, CEO and President of Philips will give an update on the latest company insights into how the worsening economic conditions are impacting Philips' performance. |
|
| Today, at the 94th annual meeting of the Radiological Society of North America (RSNA) in Chicago, Philips unveiled two innovative solutions to help radiologists save time and improve patient diagnosis. |
|
| Philips named Eric Silfen, M.D., M.S.H.A., M.A., senior vice president and chief medical officer for Philips Healthcare. Dr. Silfen joins the Philips Healthcare executive team and reports to Healthcare CEO Steve Rusckowski. Dr. Silfen will work closely with a global network of medical thought leaders to ensure that clinical insights and a people-focused approach are at the core of Philips product development and go-to-market strategies. |
|
| Philips today announced it has reached an agreement to acquire India-based Meditronics, a leading manufacturer of General X-Ray systems targeting the economy segment in India. |
|
| Already a world leader in near-patient settings, Philips has now developed a unique biosensor technology which has the potential to offer lab-quality immunoassay results at the point of care. |
|
| Philips announced today that it has completed the cancellation of in total 38,496,058 of its own shares which were acquired for cancellation during the period August 25, 2008 up to and including November 14, 2008. The average repurchase price was EUR 18.19 per share. |
|
| Eindhoven, the Netherlands – NeuroNexus Technologies and Philips Research today announced that they have signed a joint research agreement to develop next-generation deep brain stimulation devices with the ambition to improve the treatment of neurological diseases and psychiatric disorders. |